Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers.
Baykara M, Benekli M, Ekinci O, Irkkan SC, Karaca H, Demirci U, Akinci MB, Unal OU, Dane F, Turkoz FP, Balakan O, Eser EP, Ozturk SC, Ozkan M, Oksuzoglu B, Sevinc A, Demir N, Harputluoglu H, Yalcin B, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO).
Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction
Cancers. J Gastrointest Surg.
2015 Sep;19(9):1565-71. doi: 10.1007/s11605-015-2888-y. Epub 2015 Jul 16. PubMed PMID: 26179664.
